Marshall Wace North America’s Medtronic MDT Stock Holding History

Marshall Wace North America’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$39.4M	Sell	314,542 -279,406	-47%	-$36.2M	0.17%	135
2021 Q2	$73.7M	Buy	593,948 +341,006	+135%	+$42.8M	0.31%	66
2021 Q1	$29.9M	Sell	252,942 -224,295	-47%	-$26.3M	0.12%	191
2020 Q4	$55.9M	Buy	477,237 +236,942	+99%	+$26.1M	0.25%	105
2020 Q3	$25M	Buy	+240,295	New	+$24.1M	0.16%	163
2020 Q1	–	Sell	-174,747	Closed	-$19.8M	–	1448
2019 Q4	$19.8M	Buy	+174,747	New	+$19.2M	0.1%	202
2019 Q2	–	Sell	-499,191	Closed	-$45.5M	–	1413
2019 Q1	$45.5M	Buy	499,191 +269,925	+118%	+$24.2M	0.32%	88
2018 Q4	$20.9M	Sell	229,266 -1,096,612	-83%	-$102M	0.2%	103
2018 Q3	$130M	Buy	+1,325,878	New	+$123M	0.9%	28
2018 Q1	–	Sell	-273,910	Closed	-$22.1M	–	1585
2017 Q4	$22.1M	Buy	+273,910	New	+$21.9M	0.12%	200
2013 Q4	$27M	Buy	+471,083	New	+$26.7M	0.57%	47

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace North America's MDT Position: Q3 2021 in Review

Marshall Wace North America reduced its Medtronic (MDT) stake by 47% in Q3 2021, selling an estimated $36.2M and leaving 314,542 shares worth $39.4M. The position accounts for 0.17% of the portfolio, ranked #135.

Marshall Wace North America first reported a position in MDT in Q4 2013 and has held it in 11 quarters since. The position peaked at $130M in Q3 2018. 2,025 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

Marshall Wace North America held 314,542 shares of Medtronic worth $39.4M as of Q3 2021.
Marshall Wace North America sold 279,406 Medtronic shares in Q3 2021, an estimated $36.2M.
Medtronic made up 0.17% of Marshall Wace North America's portfolio in Q3 2021, its #135 holding.
Marshall Wace North America first reported a position in Medtronic in Q4 2013 and has held it in 11 quarters since.
Marshall Wace North America's Medtronic position peaked at $130M in Q3 2018.
2,025 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.